Pharmafile Logo
Pharmafocus logo
Advanced Search

Moorfields Pharmaceuticals and MC2 Biotek Group enter into a collaboration and licence agreement to develop new ophthalmic products

July 20, 2011
Manufacturing and Production

Moorfields Pharmaceuticals and MC2 Biotek have signed a collaboration and licence agreement concerning development of novel ophthalmic products addressing unmet …

News
Press release

NICE says no to breast cancer treatment Halaven

July 20, 2011
Sales and Marketing Eisai, Halaven, NICE

Eisai’s Halaven has been rejected by NICE in draft guidance for locally advanced or metastatic breast cancer. Halaven (eribulin) is …

News

Analysis paralysis – how to get the true measure of clinical trials

July 20, 2011
Research and Development Les Rose, clinical trials

The great physicist Lord Kelvin famously said: “When you can measure what you are speaking about, and express it in …

Feature

Future of AZ-BMS diabetes drug in doubt

July 20, 2011
Research and Development, Sales and Marketing AstraZeneca, BMS, dapagliflozin, diabetes, research and development news

A US advisory committee has rejected an investigational compound for type II diabetes sufferers, throwing its future into doubt. Dapagliflozin, …

News
MSD's Victrelis (boceprevir)

Hep C drug Victrelis gains EU approval

July 20, 2011
Sales and Marketing Incivek, Victrelis, hepatitis C

Merck Sharp & Dohme’s Victrelis, one of two major new hepatitis C drugs, has gained final approval in Europe. Victrelis …

News

Contract research news in brief

July 20, 2011
Research and Development research and development news

M&A abounds in the CRO sector with INC completing its purchase of Kendle, inVentiv snappig up Pharmanet and ICON buying …

News

Government seeks to salvage pharma pricing reforms

July 19, 2011
Sales and Marketing NICE, value-based pricing

The government is pushing ahead with plans to introduce value-based pricing in 2014, despite acknowledging the new system still requires …

News
Victrelis

Hepatitis C rivals go head to head

July 19, 2011
Sales and Marketing Incivek, Incivo, Victrelis, boceprevir, hepatitis C, telaprevir

 The field of hepatitis C treatment has two new groundbreaking medicines to treat the condition.Merck’s Victrelis (boceprevir) and Johnson & …

Feature
Novartis

Novartis posts double-digit sales and profit growth

July 19, 2011
Sales and Marketing Novartis

Novartis had a strong second quarter of the year, with both sales and profit up on the same period in …

News

In search of authenticity

July 19, 2011
Sales and Marketing

We don’t have a sales consultant in front of us in that situation. There is nobody to demonstrate and reassure …

Feature
Thought Leadership

Sweden seeks GMP revisions to tackle environmental pollution

July 19, 2011
Manufacturing and Production pharma manufacturing news

Wholesale shifting of pharmaceutical production to low-cost countries such as India and China is creating environmental impacts “on a scale …

News

Lonza wins another antibody contract

July 19, 2011
Manufacturing and Production Immune Pharmaceuticals, Lonza, pharma manufacturing news

Lonza has won a contract to manufacture Immune Pharmaceuticals’ antibody-based drug for inflammatory disorders, bertilimumab, at its mammalian development and …

News

New joint venture plans to tap into global generics market

July 19, 2011
Ajinomoto OmniChem, Granules India, pharma manufacturing news

Belgian fine chemicals company Ajinomoto OmniChem has forged a joint venture with Granules India to produce active pharmaceutical ingredients and …

News
ASCO 2011

ASCO 2011: news from the front line against cancer

July 18, 2011
Research and Development ASCO, Cancer, oncology

Pharmafocus presents selected highlights from the American Society of Clinical Oncology’s annual meeting in Chicago, beginning with non-small cell lung …

Feature

NICE decides laser treatment better than Lucentis

July 18, 2011
Sales and Marketing Lucentis, NICE, Novartis

Novartis says it is “disappointed” with health watchdog NICE’s decision not to recommend Lucentis for the treatment of eye problems …

News

Amgen bone cancer drug Xgeva approved in Europe

July 18, 2011
Sales and Marketing Amgen, Prolia, Xgeva, denosumab

Amgen’s bone cancer drug Xgeva (denosumab) has been approved in Europe to prevent serious bone problems in cancer patients. Already …

News
GlaxoSmithKline

GSK downsizes Irish OTC plant

July 18, 2011
Manufacturing and Production GSK, Ireland, pharma manufacturing news

GlaxoSmithKline is cutting around 130 jobs at a facility in Waterford, Ireland, over the next three years as part of …

News

Pharma manufacturing news in brief

July 18, 2011
Manufacturing and Production pharma manufacturing news

Our round-up of news in the pharmaceutical manufacturing sector includes facility updates from NanoSonic, Tianyin Pharma, Orchid and Boehringer Ingelheim, …

News
Novartis Kick Smoking iPhone app

Digital Pharma: iPhone and iPad app update

July 15, 2011
Medical Communications, Sales and Marketing Blackberry, Digital Pharma blog, ipad, iphone, mobile

How many iPads has Boehringer Ingelheim ordered for its sales force in Turkey? Do Novartis’ investors really want their annual …

News

Lophius Biosciences expands management team

July 15, 2011
Manufacturing and Production, Research and Development appointment, manufacturing and production, research and development

German biotech Lophius Biosciences has made six senior management appointments ahead of a planned 2012 market entry move. The Regensburg-based …

Appointment
The Gateway to Local Adoption Series

Latest content

Complement Therapeutics’ geographic atrophy treatment receives FDA Fast Track designation

January 22, 2026

PSI appoints David Allen as Country Manager for Canada

January 22, 2026

Qureight appoints Steven Bishop as Chief Medical Officer

January 21, 2026

Pierre Fabre Laboratories and Iktos announce oncology collaboration

January 21, 2026

Qureight appoints Rebecca Simmons as Chief Operating Officer

January 20, 2026